Sponsored Content
|Articles|May 12, 2022
Predictive Pooling Strategy: Global Biotech Company Reduces Risk in Downstream Purification
Author(s)Aizon
Read this case study on a large global biotechnology company that was looking to explore predictive models to improve the yield of their downstream bioprocess using historical data.
Related Content
Sponsored Content
Sponsored Content
Trending on Pharmaceutical Technology
1
Writing the Biological Script: Scaling DNA Manufacturing for the Next Generation of Therapeutics
2
FDA Approves Pfizer’s Breast Cancer Treatment
3
Pharma Fundamentals: Hold Times in Biopharmaceuticals
4
Q&A: Why Pharma Deal Volume Is Down but Value Is Up
5